NFLD (Northfield Labora)
All Pro Portfolios with NFLD
All Do-It-Yourself Portfolios with NFLD
- Total Do-It-Yourself Portfolios with NFLD:
- mark Portfolio 1
- Matt's Portfolio
- Phillipsman's picks
- victor czyszczon Portfolio 1
- Dariusz Portfolio 1
- Bio
- Drakir
- lance doggette Portfolio 1
- jginboca Portfolio 1
- wbts Portfolio 1
- ALOYSIUS
- TMan78 Portfolio 1
- lucky 7
- Ten years from now?
- jxrn Portfolio 1
- Over the Cliff Stocks
- Spook 1
- kartasco Portfolio 1
- fun1
- stickytrade Portfolio 1
- Raygunn82 Portfolio 1
- SUPRATRADE 1607070246
- PANTERA GROUP 129
- SUPRATRADE RED-2708070303
- My Trading Ideas
- wangjca Portfolio 1
- BP's Low-Priced Stock Fund
- Buying Cheap, See Where It Goes
- show more
- 56
- Corey Garber Portfolio 1
- CS Portfolio 1
- LisaEvenSapir Portfolio 1
- dfgfdgfd Portfolio 1
- Dariusz w Portfolio 1
- Stephen Lam Portfolio 1
- Dave Fritz Portfolio 1
- Rob1 Risky business
- Emerging Growth & Turn Arounds
- trader1968 Portfolio 1
- lancerack Portfolio 1
- jdizzie1
- ronster Portfolio 1
- gurgg Portfolio 1
- eskoptions
- highranch Portfolio 1
- the F A R M
- old_jarhead Portfolio 1
- biokid Portfolio 1
- MAIN WATCH LIST
- Sudevs
- JOHNNY HAWK
- roadrunner Portfolio 1
- bioreeder2 Portfolio 1
- catburt58 Portfolio 1
- PANTERA GROUP 149
- dagwood
- laakc
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:laakc |
Date:05 01 09 |
cheap |
|
Not yet rated
Rate now:
|
|
By:Didicus |
Date:10 25 07 |
potential |
|
Not yet rated
Rate now:
|
|
By:BD45 |
Date:09 05 07 |
I made money trading this and plan to watch volume, money flow and price action for another chance to trade it. |
|
Not yet rated
Rate now:
|
|
By:stockerblog |
Date:05 26 07 |
6.2 million short |
|
Not yet rated
Rate now:
|
|
Date:04 29 07 |
|
Has Fallen over the Cliff, but the chart shows recovery in the making. |
|
Not yet rated
Rate now:
|
|
By:kirkydu |
Date:03 03 07 |
Biotech taking a shot at the holy grail of medicine- a blood substitute. Phase 3 final data pending. Preliminary data suggested possibly one more incarnation of product necessary, which forced huge down trade resulting in current more fair price for the risk. Regardless of whether it's in the next year or next several, appears to have monster profit potential in trauma and possibly surgical fields. Buy under 5 or if trials are favorable on the way up. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Downgraded by Cowen & Co from Outperform to Neutral |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:BALD1924 |
Date:12 09 08 |
LOSS OF POSSIBILITIES |
|
Not yet rated
Rate now:
|
|
By:BigAl7734 |
Date:06 21 07 |
Biotech speculation |
|
Not yet rated
Rate now:
|
|
Date:03 29 07 |
|
TIMBER!!! The bottom fell out on this one. They really dropped the ball with their test results. The future life-saving blood substitute will be wonderful, but there needs to be some accountability upheld! |
|
Not yet rated
Rate now:
|
|
By:Robert Blum |
Date:12 21 06 |
One trick pony fighting uphill battle with charitable blood givers and moral-valued community members. |
|
Not yet rated
Rate now:
|
|